InsP 6 [Ins(1, 2, 3, 4, 5, 6)P 6 ; phytate] is the most abundant inositol phosphate in mammalian cells with cytosolic/nuclear concentrations of up to 50 μM. We noticed that InsP 6 in culture medium at a concentration of 50 μM significantly stimulates H1299 tumour cell growth, whereas larger concentrations of InsP 6 inhibit growth. A detailed study of the fate of 30 μM InsP 6 added to H199 cells revealed a major fraction of InsP 6 initially precipitates as cell-surface metal complexes, but becomes slowly re-solubilized by extracellular dephosphorylation first to InsP 3 isomers and subsequently to free myo-inositol. The precipitated metal-InsP 6 complex is endocytosed in a receptorindependent but intact-glycocalyx-dependent manner and appears in lysosomes, where it is immediately dephosphorylated to Ins(1,2,4,5,6)P 5 and very slowly to free inositol. By RNA knockdown, we identified secreted and lysosome targeted MINPP1 (multiple inositol-polyphosphate phosphatase 1), the mammalian 3-phytase, to be essentially involved both in extracellular and in lysosomal InsP 6 dephosphorylation. The results of the present study indicate that tumour cells employ this enzyme to utilize the micronutrients myo-inositol and metalphosphate when encountering extracellular InsP 6 and thus to enhance their growth potential.
INTRODUCTION
InsP 6 [Ins(1,2,3,4,5,6)P 6 ; phytate] was first detected in plants, which use it as a source of phosphorus and, due to its property to form cationic complexes, as a mineral source ( [1, 2] , reviewed in [3] ). Phytate is released into the soil by rotten plants and their remains are re-utilized by living plants. Phytasesecreting rhizosphere bacteria and fungi promote this recycling by dephosphorylation of InsP 6 (reviewed in [4, 5] ). In mammals InsP 6 was only discovered in 1985 [6] and was later reported to mainly function as a cofactor in enzymatic reactions (e.g. [7] [8] [9] ). Whether extracellular InsP 6 from dead animal cells also serves as a source of phosphate, minerals and inositol in living mammalian cells is unknown. InsP 6 is synthesized by different InsP kinases from Ins(1,4,5)P 3 (reviewed in [10] ); but, in contrast with the second messenger Ins(1,4,5)P 3 , the cellular level of InsP 6 is constitutively high (20 μM to >50 μM) in most animal cells. Apparently, all animal and eukaryotic cells "make their own InsP 6 " [11] and therefore do not need to rely upon uptake of InsP 6 from the extracellular space. The only hitherto known InsP 6 phosphatase, MINPP1 (multiple inositol-polyphosphate phosphatase 1, a member of the 3-phytase phylogenetic clade of acidic histidine phosphatases) has been shown to be predominantly localized in the lumen of the ER (endoplasmatic reticulum) [12, 13] . Apparent extracytosolic restriction of a phytase leads to stable accumulation of high cytosolic InsP 6 concentrations in mammalian cells [12, 13] and leaves the physiological function of mammalian MINPP1 as a mystery. In minpp1 − / − mice no obvious phenotype has been observed yet [13] .
In addition to the physiological intracellular function of InsP 6 , it has been shown that still higher concentrations ( 100 μM) of InsP 6 added extracellularly inhibit proliferation of tumour cells (reviewed in [14] ). The mechanism of this antiproliferative effect of InsP 6 has not been elucidated in its molecular details yet, but there are indications for possible extracellular and intracellular effects of InsP 6 leading to inhibition of cell growth. Since InsP 6 forms high-affinity complexes with polyvalent cations such as Ca 2 + , Mg 2 + , Zn 2 + and Fe 3 + [15] [16] [17] [18] , many groups assume that the antiproliferative effect of InsP 6 results from depletion of essential cations from the medium (e.g. [11] ). Some groups postulate that endocytosed InsP 6 or its dephosphorylation products directly influence the expression and activation of cellular enzymes involved in apoptosis and proliferation (reviewed in [14] ). The potential effects of lower concentrations of InsP 6 ( 50 μM) emerging from necrotic cells in tumour tissue on living tumour cells within these regions have not been examined in detail previously.
We unexpectedly found that a low concentration of extracellular InsP 6 ( 50 μM) adversely stimulated and did not inhibit proliferation of H1299 tumour cells. We clarified cellular and molecular details of the mechanisms behind this growthpromoting effect of InsP 6 and demonstrate in the present study that this behaviour relies upon novel cellular functions of the MINPP1 enzyme as a secreted and lysosomal 3-phytase allowing animal cells to utilize myo-inositol phosphate and complexed cations from extracellular phytate.
EXPERIMENTAL Determination of cell proliferation
H1299 cells (1×10 4 per well) were seeded in 96-well plates and incubated at 37
• C and 5% CO 2 for 24, 48 and 72 h. Growth was determined by counting trypsinized cells using a CASY-1 cell counter (Scharfe System). Viability was always tested by Trypan Blue exclusion counting.
Treatment of cells with InsP 6 and analysis of inositol phosphates by MDD (metal dye detection)-HPLC
H1299 cells [a non-small cell lung carcinoma cell line derived from a lymph node metastasis (A.T.C.C., Manassas, VA, U.S.A)], were seeded into 15 cm dishes and grown in DMEM (Dulbecco's modified Eagle's medium)/10 % FBS (fetal bovine serum) to 80 % confluence. Then 30 μM InsP 6 (Calbiochem #40125, Merck) diluted in 250 μl of distilled water or water alone as a control were carefully distributed over all of the cells. After incubation for 16 h, 24 h or longer, the cells were washed six times for 20 s with 5 ml of PBS and cellular inositol phosphates were extracted with ice-cold TCA (trichloroacetic acid) as described in [19] and analysed by MDD-HPLC as described in [20] . In addition, 1 ml of the medium was treated with 10 % TCA and after centrifugation at 13 000 g for 15 min the supernatant was analysed by MDD-HPLC.
For . This solution was mixed with 5 ml of DMEM/10 % FBS and applied to H1299 cells, which were grown on 10-cm-diameter dishes to 80 % confluence in the same medium. After incubation for different time points, the cells were washed six times with PBS and inositol phosphates were extracted from cells as described in [19] . Cell extracts were subjected to MDD-HPLC [20, 21] and fractions were collected at appropriate intervals.
3 H-labelled inositol phosphates in collected fractions was determined by liquid scintillation counting (FLO-SCINTTM IV, Pachard Instruments) after adding 2 ml of InstaGel Plus scintillator (PerkinElmer) per fraction. [20, 21] of isomeric purity. Pooled fractions 14 and 15 containing pure [4,5- 32 P]InsP 6 (6.2×10 6 c.p.m., 1 ml) were neutralized with 2 M Tris base, mixed with 3 μl 100 mM non-labelled InsP 6 and diluted in 10 ml of DMEM/10 % FBS to give a final concentration of 30 μM. H1299 cells grown to approximately 80 % confluence were incubated for 16 h with this [
32 P]InsP 6 -supplied medium. Thereafter, cells were lysed and fractioned as described below.
Cell fractionation using differential centrifugation H1299 cells, washed five times with PBS and once with icecold fractionation buffer (10 mM Tris/HCl, pH 7.5, and 250 mM sucrose), were homogenized in 1 ml of fractionation buffer in a tight fitting glass/glass Potter Elvehejm for 3-4 min at 4
• C (40 strokes). Homogenized samples were differentially centrifuged using a TL 100 micro-ultra centrifuge (Beckman Coulter) at 4
• C for 2 min each. Pellet P1 (cell fractions plus nuclei) was obtained after centrifugation at 4000 g, P2 resulted from centrifugation of the resulting supernatant at 8000 g, P3 from centrifugation of the latter supernatant at 100 000 g and P4 from the centrifugation of the 100 000 g supernatant at 400 000 g. Pellets were resuspended in 75 μl of MPER lysis buffer (Promega) supplemented with PhosStop and protease inhibitor (Roche) according to the manufacturers' protocols, and subsequently frozen and thawed twice in liquid nitrogen. The protein concentration of solubilized pellets and in supernatants was determined by the Bradford [22a] assay. For analysis of inositol phosphate masses and radioactivities by MDD-HPLC, four such fractionation experiments were combined. Pellets and supernatants frozen in liquid nitrogen were re-thawed, pooled and extracted with TCA as described in [19] . Inositol phosphates were analysed by MDD-HPLC [20, 21] and the [4- 32 P]-and/or [5-32 P]-phosphate radioactivity in fractions collected at appropriate intervals was measured by Cerenkov radiation counting (Wallac LSC 1409).
Extraction of protein lysates for Western blot analysis
To prepare whole-cell lysates, cells were washed three times with ice-cold PBS, scraped with a rubber policeman and resuspended in MPER lysis buffer supplemented with protease inhibitor and PhosStop. The samples were frozen twice in liquid nitrogen, thawed and centrifuged at 4
• C and 13 000 g for 15 min. The protein concentration of the supernatant was determined by the Bradford [22a] assay. For analysis of secreted MINPP1, 2 ml of cell culture medium from cells cultivated for 48 h were treated with 10 % TCA, incubated on ice for 15 min and centrifuged for 15 min at 13 000 g. Finally the pellet was washed twice with isopropanol, resuspended in sample buffer and neutralized with 2 M Tris base. For Western blot analysis, 20 μg of cellular protein and the TCA pellet of 2 ml cell culture medium were subjected to SDS/PAGE (10 % gels) and standard immunoblotting techniques were applied. Signals were detected using the ECL (enhanced chemiluminescence) system (Amersham Biosciences) with a Fuji BAS-1000 imaging analyser.
Immunofluorescence
Cells were grown to 60 % confluence in chamber slides, washed twice with PBS, fixed with methanol (98 %, − 20
• C) on ice for 10 min at 20
• C and washed three times with PBS. For immunofluorescence applications, cells were blocked in 1 % BSA/PBS (Sigma-Aldrich) for at least 40 min, incubated with the anti-MINPP1 antibody (Santa Cruz Biotechnology #sc-10399) in a dilution of 1:100 in 0.7 % BSA/PBS at 8 • C overnight, and then incubated with an anti-goat Alexa Fluor ® 488-coupled secondary antibody (Invitrogen) at 1:8000 dilution in 0.7 % BSA/PBS for 1 h at 22
• C. Between each step cells were washed three times with PBS. To examine a potential co-localization of MINPP1 with endosomes and lysosomes or Golgi vesicles, one chamber each of anti-MINPP1-antibody-stained cells was treated with an antibody against EEA1 (early endosome antigene 1) (Abcam, ab2900), LAMP-2 (lysosome-associated membrane protein-2) (Santa Cruz Biotechnology, #sc-5571), Golph4 (Golgi integral membrane protein 4; GOLIM4) (Santa Cruz Biotechnology, #sc-10399) or calnexin (Santa Cruz Biotechnology, #sc-70481) at 1:200 dilution in 0.7 % BSA/PBS for 16 h at 8
• C. After washing again three times with PBS, the cells were finally treated with anti-(rabbit EEA1), anti-(rabbit Lamp-2), anti-(mouse Golph4) or anti-(mouse calnexin) Alexa Fluor ® 568-coupled secondary antibodies at 1:1000 dilution for 1 h at 22
• C. After washing the cells with PBS, images were captured with a confocal microscope (LSM510, Zeiss MicroImaging).
Stable knockdown MINPP1 expression in H1299 cells
Stable down-regulation of MINPP1 expression was performed by using a lentiviral approach as described in [23] .
RESULTS

Effect of extracellular InsP 6 on tumour cell proliferation
In order to compare the effect of pharmaceutical and physiological extracellular InsP 6 concentrations on tumour cell proliferation, lung tumour cells (H1299) were treated with 1-100 μM extracellular InsP 6 for several days . As a control, H 2 O was added to the cell culture medium of control cells. After incubation for 24 h, 48 h and 72 h, the cell number was counted. The experiments were performed in triplicate. As shown in Figure 1 , cells incubated with 1-75 μM InsP 6 showed a significant increase in proliferation after 48 h and 72 h in comparison with the control cells. In contrast, incubation with 100 μM InsP 6 for 72 h significantly reduced the growth of H1299 cells. Thus, the effect of InsP 6 on tumour cell proliferation is strongly concentrationdependent. Low concentrations of InsP 6 ( 75 μM) stimulate cell proliferation, whereas concentrations 100 μM have an inhibitory effect. 
InsP 6 is dephosphorylated after cellular uptake
To investigate whether the observed effect of InsP 6 on tumour cell proliferation results from extracellular or intracellular effects of InsP 6 , we measured changes in intracellular inositol phosphate levels after incubation with extracellular InsP 6 . Therefore we analysed the uptake of InsP 6 into H1299 cells in detail. First, cells were incubated with unlabelled InsP 6 for 24 h and cellular extracts of InsP 6 (30 μM)-and H 2 O (control)-treated cells were analysed by MDD-HPLC. We found that the concentration of InsP 6 was increased 21-fold and that of Ins(1,2,4,5,6)P 5 and Ins(1,3,4,5,6)P 5 was increased 72-and 2-fold respectively, when compared with untreated cells (Figure 2 ). These results clearly confirm that tumour cells are able to internalize extracellular InsP 6 and subsequently dephosphorylate this inositol phosphate, as previously found by Vucenik and Shamsuddin [24] and Ferry et al. [25] .
Extent of InsP 6 dephosphorylation after and prior to cellular uptake
In order to follow the extent of dephosphorylation of InsP 6 after endocytosis, H1299 cells were incubated with 3 H] radioactivity after 1 week of incubation and obviously was re-phosphorylated to phosphatidylinositol as we detected low levels of 3 H-labelled phosphatidylinositol in the cell extracts ( Figure 3B) . Also in the cell culture medium dephosphorylation of InsP 6 was observed over time ( Figures 3C and 3D ), but the rates and the products of dephosphorylation were different from those observed in the cell extracts. InsP 6 was completely dephosphorylated after 168 h of incubation and in this case the main dephosphorylation product was not Ins(1,2,4,5,6)P 5 but InsP 3 , representing 61 % of total 3 H radioactivity after 72 h and 47 % after 168 h of incubation. Again, InsP 3 was completely dephosphorylated to inositol, but in the medium production of inositol was first visible after 72 h of incubation. After 168 h of incubation with [ 3 H]InsP 6, the [ 3 H]-inositol signal represented 32 % of total radioactivity, and was 10-fold higher than that measured in cell extracts.
The fact that the Figure S2) . In summary, our results reveal that extracellular InsP 6 associates with the cell and/or the culture dish surface and re-dilutes into the medium over time of incubation. Soluble InsP 6 is dephosphorylated to InsP 3 , which after long incubation times (72-168 h) is dephosphorylated to inositol. In addition, a fraction of InsP 6 3 H]InsP 6 -derived inositol is utilized to synthesize phosphatidylinositol, because we detected production of 3 H-labelled phosphatidylinositol after 1 week of incubation ( Figure 3B ).
InsP 6 associates with cell-surface molecules
To further distinguish between precipitation of InsP 6 at the cell surface and the surface of cell culture dishes, InsP 6 (30 μM)-containing medium was applied to cell-free Petri dishes or to Petri dishes with H1299 cells grown to approximately 80 % confluence. At different time points between 10 min and 2 h, the InsP 6 concentration in the medium and in the wash fractions (1-6) was analysed by MDD-HPLC as described above. The wash fractions from InsP 6 -treated Petri dishes contained 0.7 and 6 μg of InsP 6 after 10 min and 2 h of incubation respectively (Supplementary Figure S4A at http://www.biochemj.org/bj/450/ bj4500115add.htm) . Thus approximately 20 % of the initially added 30 μM InsP 6 precipitated within 2 h. The precipitated InsP 6 could be removed from the dishes almost completely by one wash step, independent from previous precipitation time (Supplementary Figure S4B) . In the wash fractions of Petri dishes containing growing cells, the InsP 6 concentration was lower than that of the cell-free Petri dishes (37 % after 10 min and 64 % after 2 h of incubation, Supplementary Figure S4C ). Furthermore, after 2 hours of incubation, three wash steps were needed to dissolve InsP 6 from the cell surface (Supplementary Figure  S4D) . This clearly shows that InsP 6 precipitates are more tightly associated with the cell surface than with the surface of Petri dishes (plastic).
Uptake of InsP 6 is not receptor-mediated
On the basis of our finding above that InsP 6 or InsP 6 complexes interact with cell-surface molecules, we investigated whether InsP 6 might bind to a low-affinity receptor and is subsequently internalized by receptor-mediated endocytosis. Receptor-mediated uptake mostly occurs by clathrin-dependent endocytosis, whereas unspecific-and other large-vesiclemediated uptake of extracellular substances can be mediated by different endocytotic pathways (clathrin, caveolin/flotillinmediated endocytosis pathways; for a review see [26] ). Receptormediated uptake occurs very fast (<5 min) and clathrin-mediated endocytosis is dependent on Rab5, a small GTPase, which activates EEA1, a protein that mediates fusion between clathrincoated vesicles and early endosomes [27] . On the basis of these considerations, the time-course of InsP 6 uptake was analysed ( Figure 4A ) as well as its uptake after overexpression of a dominant-negative mutant of Rab5 ( Figure 4B) . Uptake of InsP 6 first started after 10 min of its addition and dephosphorylation to Ins(1,2,4,5,6)P 5 was first detected after 120 min. Both uptake and dephosphorylation of InsP 6 were not different between the control cells and those overexpressing a dominant-negative mutant of Rab5. Thus uptake of InsP 6 is not mediated by clathrin-and receptor-dependent endocytosis, but by a slow non-receptormediated endocytosis mechanism.
Endocytosis of InsP 6 is dependent on the presence of cations
Since our results above reveal that uptake of InsP 6 is not mediated by rapid receptor-specific endocytosis, we analysed further details of InsP 6 uptake. It is well known that InsP 6 Thus it may be possible that InsP 6 associates with the cell surface as a multivalent cationic complex. To examine this assumption, the dependence of InsP 6 uptake on the presence of divalent cations was analysed. Therefore InsP 6 was dissolved at a concentration of 30 μM either in minimal medium containing only 20 mM Hepes buffer, 5 mM KCl, 140 mM NaCl, 1 mM NaH 2 PO 4 and 5 mM glucose, but no divalent cations (a condition in which H1299 cells survive for 6 h) or in complete medium (DMEM/10 % FBS). Both media were added to cells grown to 80% confluence in cell culture dishes. After 3 h of incubation, inositol phosphates were extracted and analysed by MDD-HPLC (Supplementary Figure S5 at http://www.biochemj. org/bj/450/bj4500115add.htm). In cells incubated with InsP 6 in complete medium, the cellular concentration of InsP 6 increased to 130 μM, whereas the medium concentration decreased to 11 μM. In contrast, no significant change in InsP 6 concentration was detected in cells that were treated with InsP 6 in Ca 2 + -and Mg 2 + -free minimal medium and the InsP 6 concentration of the minimal medium remained unchanged at 30 μM. This analysis clearly shows that endocytosis of InsP 6 is dependent on complex formation with multivalent cations.
Cationic InsP 6 complexes associate with cell surface molecules
Our results from the present study showed that InsP 6 binds more tightly to the surface of cells than to plastic and that its uptake depends on the presence of multivalent cations. This might be due to a metal-InsP 6 complex binding to the negatively charged glycocalyx in the form of 'sandwich complexes'. To analyse this hypothesis, the cells were treated with tunicamycin, a drug that partially degrades the glycocalyx. This experiment showed that treatment with tunicamycin inhibited uptake of InsP 6 by 37 % (Supplementary Figure S6A at http://www. biochemj.org/bj/450/bj4500115add.htm). In accordance with this result, the InsP 6 concentration in the medium was increased by 64 % in cells treated with tunicamycin. Compared with control cells which were not treated with tunicamycin, the InsP 6 concentration in wash number 1 was doubled in tunicamycintreated cells. This result shows that disruption of the glycocalyx reduces the affinity of InsP 6 -metal complexes to the cell surface (Supplementary Figure S6B) .
Taken together, we conclude that InsP 6 precipitates as a multivalent cationic complex at the cell surface, interacts with the glycocalyx and is subsequently endocytosed as a cationic complex by non-receptor-mediated endocytosis.
After endocytosis, InsP 6 is dephosphorylated in endosomes/lysosomes
To examine whether after endocytosis InsP 6 is dephosphorylated in endosomes/lysosomes or in the cytoplasm, H1299 cells were incubated with [ 32 P]InsP 6 for 16 h, lysed and ultracentrifugated to generate different cell fractions: a 4000 g pellet (P1: cell fragments and nuclei), a 8000 g pellet (P2: fragments of nuclei), a 100 000 g pellet (P3: organelles and microsomes) and the supernatant (S/N: microsomes, plasma membranes and cytoplasm). We did not generate 400 000 g pellets to separate small organelles and plasma membranes from the cytoplasm, because the volume of the 400 000 g pellets would have been too small to extract inositol phosphates suitable for HPLC analysis. Thus the supernatant contains microsomes, membranes and cytoplasm.
To analyse the success of the fractionation we measured the level of marker proteins in protein extracts of the different fractions (including P4, the 400 000 g pellet) by Western blotting ( Figure 5A ). In P1-P3, calnexin, an ER marker protein, was detected, with the highest concentration in P2. The early endosome protein EEA1 was highest concentrated in P3, the Golgi network protein Golph4 in P4 and the lysosome protein LAMP-2 was enriched in P3.
Inositol phosphate analysis of the fractions revealed that the concentration of [ 32 P]InsP 6 decreased from P1 to P3, whereas the ratio of [ 32 P]Ins(1,2,4,5,6)P 5 to [ 32 P]InsP 6 increased ( Figure 5B ). In P1, the Ins(1,2,4,5,6)P 5 content was 55 %, in P2 68% and in P3 87% on the basis of the total Ins (1,2,4 Figure 5B ) could also result from extracellular bound [ 32 P]InsP 6 , since the supernatant still contained plasma membrane fragments.
Our result that Ins(1,2,4,5,6)P 5 is the most abundant InsP in the endosomal/lysosomal fractions indicates that dephosphorylation of InsP 6 occurs in endosomes/lysosomes. To verify this, H1299 cells were treated with NH 4 Cl 2 to prevent transport of enzymes from the ER to lysosomes [28] . After 24 h, 48 h, 72 h and 1 week of incubation with either InsP 6 only (control) or with InsP 6 plus NH 4 Cl 2 , inositol phosphates were extracted and analysed by MDD-HPLC as described above ( Figure 5C ). As expected, the control cells contained high levels of Ins(1,2,4,5,6)P 5 after incubation with InsP 6 and the concentration of InsP 6 decreased after 72 h to 168 h of incubation. In cells treated with NH 4 Cl 2 , production of Ins(1,2,4,5,6)P 5 was inhibited by 85 % after 48 h to 72 h of incubation and by 72 % after 1 week of incubation. Accordingly, the InsP 6 level increased up to 72 h of incubation in cells treated with NH 4 Cl 2 and started to decrease after 1 week of incubation.
Taken together, these results clearly demonstrate the requirement of lysosomal enzymes for production of Ins(1,2,4,5,6)P 5 from endocytosed InsP 6 .
Localization of MINPP1 in lung tumour cells
Next, we examined the enzyme(s) involved in dephosphorylation of InsP 6 in cells and in the extracellular space. Since MINPP1 is the only known InsP 6 phosphatase, a potential involvement of MINPP1 in the dephosphorylation of InsP 6 was investigated. On the basis of the fact that until now MINPP1 has only been detected within the ER [12, 13] , the physiological function of this phosphatase remained elusive. However, Golgi proteins as well as lysosomal proteins mature in the ER [29] . Therefore we examined a potential MINPP1 localization in endosomes/lysosomes and in Golgi vesicles.
First, the level of MINPP1 was analysed in P1-P4 and in the cytoplasmatic fraction of H1299 cells. The highest level of MINPP1 was detected in P3, containing early endosomes and lysosomes as well as ER fragments, and in P4, enriched with plasma membranes and Golgi vesicles ( Figure 6A ). To confirm this potential localization of MINPP1 in microsomes, the distribution of MINPP1 within cells was examined. Therefore we detected MINPP1 and the respective marker proteins for ER, endosomes, Golgi and lysosomes (calnexin, EEA1, Golph4 and LAMP-2) by indirect double immunofluorescence. A potential co-localization of MINPP1 and the marker proteins was analysed by merging the red and green fluorescent signals ( Figure 6B , right-hand panels). This analysis revealed a clear colocalization of MINPP1 and Golgi vesicles and a partial co-localization of MINPP1 and lysosomes as well as MINPP1 and the ER, confirming the data shown in Figure 6 (A). However, a co-localization of MINPP1 and endosomes containing EEA1 was not detectable.
Since most proteins which are located in Golgi vesicles are secreted [26] , we additionally examined the level of MINPP1 in the culture medium of H1299 cells by Western blot analysis and detected a band at 47 kDa in the cell lysate and at 52 kDa in the medium ( Figure 6C ). The 47 kDa band represents the molecular mass of MINPP1. The higher molecular mass band detected in the culture medium may result from glycosylation of MINPP1, because most proteins are glycosylated in the trans-Golgi network prior to secretion [26] and MINPP1 was predicted to have N-linked glycosylation at two sites (position 242, Asn-Ala-Thr; 481, Asn-Ser-Thr; http://www.uniprot.org/ uniprot/Q9UNW1).
Taken together, these data show MINPP1 localization in the ER, lysosomes, in Golgi vesicles and in the culture medium, whereas no MINPP1 was detectable within EEA1-labelled endosomes. Thus it is likely that MINPP1 catalyses dephosphorylation of InsP 6 in the extracellular space and in lysosomes.
MINPP1 is essential for dephosphorylation of InsP 6 after and prior to cellular uptake
In order to more precisely examine the impact of MINPP1 on dephosphorylation of intra-and extra-cellular InsP 6 , expression of MINPP1 was down-regulated by five different MINPP1 shRNAs (small hairpin RNAs) using a lentiviral approach. Treatment with scrambled shRNA served as a control. The most efficient (A) To separate cell compartments, lysed cells were centrifuged at different speeds as described in the Experimental section and analysed by Western blotting. To identify fractions enriched with ER, endosomes/lysosomes and Golgi vesicles, antibodies against marker proteins were applied: ER, calnexin; endosomes, EEA1; lysosomes, LAMP-2; and golgi vesicles, Golph4. CL, cell lysate; S/N, supernatant. (B) Cells were treated with 30 μM InsP 6 spiked with 32 P-labelled InsP 6 as described in the Experimental section. After incubation for 16 h, cells were lysed, centrifuged at different speeds as described in the Experimental section and inositol phosphates were extracted from P1 to P3 as well as from the supernatant. These extracts were analysed by MDD-HPLC and by liquid scintillation counter. The counts (left-hand axis) and adsorption at 520 nm (right-hand axis) against retention time are shown. The arrows indicate peaks for InsP 6 down-regulation of MINPP1 expression was detected in MINPP1 sh#2 and MINPP1 sh#4 cells (approximately 80 %, Figure 7A ). We incubated these two knockdown cell lines and control cells with InsP 6 and compared dephosphorylation of intra-and extracellular InsP 6 . As shown in Figure 7 (B), 200 % and 400 % more InsP 6 remained in the medium of MINPP1 sh#2 and MINPP1 sh#4 cells respectively. The concentration of the InsP 6 dephosphorylation products InsP 2 and InsP 3 remained lower than in control cells [70 % (sh2) and 80 % (sh4), Figure 7B ]. In accordance with the observed high InsP 6 concentration in the medium, cells with reduced MINPP1 expression exhibited a significantly higher intracellular concentration of InsP 6 compared with control cells (sh2, 190 %; sh4, 250 %) ( Figure 7C ). However, this high InsP 6 level in MINPP1 shRNA cells was not accompanied by a higher production of Ins(1,2,4,5,6)P 5 , but the ratio between Ins(1,2,4,5,6)P 5 and InsP 6 was reduced by 50 % (sh2) to 60 % (sh4) in MINPP1 shRNA cells ( Figure 7D ). Thus MINPP1 is essentially involved in production of intracellular Ins(1,2,4,5,6)P 5 from InsP 6 . These data together with the results depicted in Figure 6 indicate that secreted MINPP1 dephosphorylates extracellular InsP 6 to InsP 3 , whereas lysosomal MINPP1 mediates dephosphorylation of intracellular InsP 6 to Ins(1,2,4,5,6)P 5 .
DISCUSSION
In the present study we examined the effect of physiological and pharmaceutical InsP 6 concentrations on proliferation of tumour cells and the mechanism behind this effect. As expected, we confirmed the well-documented inhibition of tumour cell growth by high levels of InsP 6 ( 100 μM) (summarized in [14] ). In addition, we show that low InsP 6 concentrations (1-50 μM) stimulate growth of lung tumour cells. This observation was also made by Eagle et al. [30] who examined the effect of inositol on cell proliferation and tested several inositol-related substances as a control. They found that inositol significantly stimulates cell growth and discovered that only InsP 6 (1 μM) and inositol monophosphate had proliferation-promoting effects, although to a lower extent as observed for inositol. Since our results from the present study show that extracellular InsP 6 is dephosphorylated to inositol in the medium and after cellular uptake, we suggest that the proliferation-stimulating effect of InsP 6 results from increased production of inositol and, additionally, from release of metal-phosphate from InsP 6. Thus living cells of solid tumours may use InsP 6 , which is released from necrotic tumour cells, as an additional source of micronutrients to increase their mitogenic potential. However, this positive property of low InsP 6 levels can switch completely at higher concentrations. Because only approximately 20 % of extracellular InsP 6 is being endocytosed, the remaining extracellular InsP 6 depletes essential di-and tri-valent cations (Ca 2 + , Mg 2 + and Fe 3 + ) from the cell culture medium, which leads to inhibition of cell growth. This explanation of the antiproliferative effect of pharmaceutical InsP 6 is more plausible than the assumption that InsP 6 or its dephosphorylation products directly influence proteins involved in the control of proliferation and apoptosis (summarized in [14] ). First, the antiproliferative effect of InsP 6 is highest after 6 days of incubation [25] . At this time point most of the InsP 6 has already been dephosphorylated. Secondly, InsP 6 is separated from cytoplasmatic enzymes by its entrapment in endosomes/lysosomes. Therefore the observed modification of intracellular proteins [14] after application of InsP 6 to the medium may rather result from cation starvation than from direct interaction of InsP 6 with cellular proteins.
The mechanism of endocytosis of InsP 6 can also be explained by interaction of InsP 6 with di-and tri-valent cations. The results from the present study indicate that InsP 6 binds to the glycocalyx and demonstrate that uptake of InsP 6 only occurs in the presence of di-and tri-valent cations, but is not dependent on clathrin-or receptor-mediated endocytosis. These data and the finding of Poyner et al. [16] , showing that Ca 2 + and Mg 2 + increase the concentration of InsP 6 at the cell surface, strongly suggest that InsP 6 -cation complexes interact with negatively charged molecules of the glycocalyx, such as N-acetylneuraminic acid [31] and are subsequently endocytosed. After endocytosis of InsP 6 , the concentration of metal-phosphate (approximately 600 μM in cell extracts and thus approximately 2 mM in endosomes/lysosomes) is much higher than the soluble concentration of InsP 6 (50 μM, [17] ). These metal-phytate precipitates become metal-free after fusion of endosomes with lysosomes, because under acidic conditions in lysosomes, protonation of the phosphate groups of InsP 6 generates its metal-free form. The resulting soluble fraction can then be dephosphorylated initially to Ins(1,2,3,4,5,6)P 5 and finally to inositol. On the basis of our observation that this InsP 6 -derived inositol is re-phosphorylated to phosphatidylinositol, it must have been transported from the lysosomes into the cytosol, presumably via lysosomal membranes by the acidic HMIT (H + /myo-inositol symporter [32] ). In addition, extracellular InsP 6 -derived inositol may have been transported via the plasma membrane into the cytosol by the plasma membrane SMIT (Na + /myo-inositol transporter [33] ). Both of the inositol transporters SMIT and HMIT were found to be expressed in H1299 cells (results not shown). Ca 2 + , Mg 2 + and Fe 3 + , which are released after dephosphorylation of InsP 6 , may be transported by lysosomal cation transporters, such as TRPML1 (transient receptor potential channel 1) or NRAMP (natural resistance-associated macrophage protein) [34, 35] .
In addition to the physiological relevance of extracellular InsP 6 and its cellular uptake, we examined the mechanism of InsP 6 dephosphorylation prior and after cellular uptake, and found that MINPP1 is essentially involved in this process. Reduction of the cellular MINPP1 level by an RNAi (RNA interference) approach strongly decreased the dephosphorylation of InsP 6 in the medium as well as in lysosomes after endocytosis of InsP 6 . Furthermore, we show that MINPP1, which has previously been described as an ER-targeted InsP 6 phosphatase [12, 13] , is transported into lysosomes and is secreted into the medium. This translocation explains why MINPP1 is able to dephosphorylate lysosomal and extracellular InsP 6 . The enzymatic characteristics of MINPP1 have been extensively studied by Shears and coworkers [36] [37] [38] . They demonstrated that purified rat MINPP1 dephosphorylates InsP 6 to InsP 3 in vitro and also determined the kinetic parameters for this reaction: MINPP1 binds InsP 6 with high affinity (K m = 0.3 nM), but has a low specific activity for InsP 6 dephosphorylation (12 nmol/mg/min). In contrast the affinity for InsP 5 and InsP 4 is much lower (133-433-fold), and dephosphorylation of these substrates occurs with 20-300-fold higher enzyme activity as compared with dephosphorylation of InsP 6 [36] . These enzymatic characteristics of MINPP1 may explain why, in the medium, InsP 6 is slowly dephosphorylated to InsP 5 , which is then quickly dephosphorylated to InsP 3 . In addition, Nogimori et al. [36] showed that MINPP1 has a pH optimum of 7.4, thus, under acidic conditions in lysosomes, the phosphatase activity is inhibited. On the basis of this finding, we assume that the very slow dephosphorylation of InsP 5 to InsP 3 in lysosomes is due to inhibition of MINPP1 by the acidic pH. Further dephosphorylation of InsP 3 to inositol in lysosomes and in the medium, however, must be catalysed by hitherto unidentified lysosomal and extracellular phosphatases respectively, because even under optimal conditions MINPP1 does not further dephosphorylate InsP 3 [36] .
In summary, the results from the present study show that MINPP1 is the phosphatase that catalyses the first steps of InsP 6 dephosphorylation in the extracellular space as well as in lysosomes after endocytosis of InsP 6 . Prior to this finding the physiological function of MINPP1 in mammalian cells was unclear because its localization in the ER separates MINPP1 from its InsP substrates in the cytoplasm [12] . Our results now provide evidence that, at least in tumour cells, the physiological function of MINPP1 is: (i) to protect tumour cells from the growth-inhibitory effect of InsP 6 by limiting the extracellular InsP 6 concentration; and (ii) to mediate mobilization of inositol, phosphate and di-and tri-valent cations from endocytosed InsP 6 to increase the concentration of these micronutrients. Therefore MINPP1 provides tumour cells with a tool to increase their mitogenic potential.
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